| Pharmaceutical active ingredients: |
| Ethinyl EstradiolNorethindrone Acetate |
| Available forms, composition and doses of Prosiston: |
| N / A |
| Prosiston medical category: |
| Human:Oral contraceptives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03AA05 - Norethisterone and estrogenG03AB04 - Norethisterone and estrogenG03CA01 - Ethinylestradiol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bayer Schering Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Norlestrin | Ethinyl Estradiol; Norethindrone Acetate | Pfizer; Parke-Davis |
| Orlest | Ethinyl Estradiol; Norethindrone Acetate | Pfizer; Parke-Davis |
| Ostro-Primolut | Ethinyl Estradiol; Norethindrone Acetate | Bayer Schering Pharma |
| Primosiston Tablets | Ethinyl Estradiol; Norethindrone Acetate | Bayer Schering Pharma |
| Progylut | Ethinyl Estradiol; Norethindrone Acetate | Bayer Schering Pharma |
| Sequostat | Ethinyl Estradiol; Norethindrone Acetate | Jenapharm |
| Trentovlane | Ethinyl Estradiol; Norethindrone Acetate | Bayer Schering Pharma |
| Tri-Legest | Ethinyl Estradiol; Norethindrone Acetate | Barr Laboratories |
| Tri-Legest Fe | Ethinyl Estradiol; Norethindrone Acetate | Barr Laboratories |
| Cilest | Ethinyl Estradiol; Norgestimate | Janssen; Codepharma Laboratoire; Johnson & Johnson |